Defining and Characterizing the Progression of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is a progressive disease in which the risks of myocardial infarction, stroke, microvascular events, and mortality are all strongly associated with hyperglycemia (1). The disease course is primarily characterized by a decline in �-cell function and worsening of insulin resistance. The process is manifested clinically by deteriorations in multiple parameters, including A1C, fasting plasma glucose (FPG), and postprandial glucose levels. In this review, we will evaluate our current understanding of the role played by deteriorating �-cell function and other abnormalities linked with the progression of type 2 diabetes. An improved understanding of these abnormalities may provide the scientific groundwork for novel therapies that may help achieve and maintain good glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, the essential oil extracted from CW, primarily comprising esters (58.3%) and ketones (33.5%), has also demonstrated notable free radical scavenging activity and antioxidant potential [49].”
From Research Progress in Coconut Water: A Review of Nutritional Composition, Biological Activities, and Novel Processing Technologies (2025) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Regardless of the treatment regime, longitudinal studies in humans have demonstrated that beta-cell function generally deteriorates over time.49,50”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Following the induction of insulin resistance, islet beta-cells can maintain normoglycaemia and metabolic homeostasis by increasing their secretion of insulin and/or by increasing their number.49,96,97”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“The gradual decline in islet beta-cell number and function results in insulin levels becoming too low to promote metabolic homeostasis and T2D results.49,91”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Obesity has been estimated to induce an ~50% increase in islet beta-cell volume due to increased neogenesis.49”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Human temperature regulation under heat stress in health, disease, and injury
Cramer, M. N., Gagnon, D., Laitano, O., & Crandall, C. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00047.2021 · Cited by 491
Lim, J., Kim, J., Koo, S. H., & Kwon, G. C. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212963 · Cited by 464
Environmental Risk Factors for Developing Type 2 Diabetes Mellitus: A Systematic Review
Dendup, T., Feng, X., Clingan, S., & Astell-Burt, T. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010078 · Cited by 440
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Li, X., Dunn, J., Salins, D., Zhou, G., Zhou, W., Schüssler-Fiorenza Rose, S. M., Perelman, D., Colbert, E., Runge, R., Rego, S., et al. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2001402 · Cited by 431
Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma, S., & Tripathi, P. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.10.003 · Cited by 428
Rosenstock, J., Hansen, L., Zee, P., Li, Y., Cook, W., Hirshberg, B., & Iqbal, N. (2015) · Diabetes Care · doi:10.2337/dc14-1142 · Cited by 290
Jabbour, S. A., Hardy, E., Sugg, J., Parikh, & for the Study 10 Group (2014) · Diabetes Care · doi:10.2337/dc13-0467 · Cited by 286
Baz, B., Riveline, J.-P., & Gautier, J.-F. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0378 · Cited by 260
Khunti, K., Nikolajsen, A., Thorsted, B. L., Andersen, M., Davies, M. J., & Paul, S. K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12626 · Cited by 256
Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus
Reach, G., Pechtner, V., Gentilella, R., Corcos, A., & Ceriello, A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.06.003 · Cited by 251
Marine Algae-Derived Bioactive Compounds: A New Wave of Nanodrugs?
Menaa, F., Wijesinghe, U., Thiripuranathar, G., Althobaiti, N. A., Albalawi, A. E., Khan, B. A., & Menaa, B. (2021) · Marine Drugs · doi:10.3390/md19090484 · Cited by 240
Zambrowicz, B., Freiman, J., Brown, P. M., Frazier, K. S., Turnage, A., Bronner, J., Ruff, D., Shadoan, M., Banks, P., Mseeh, F., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.58 · Cited by 243
Role of polyphenols in combating Type 2 Diabetes and insulin resistance
Shahwan, M., Alhumaydhi, F., Ashraf, G. M., Hasan, P. M. Z., & Shamsi, A. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.004 · Cited by 223
Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications
Wysham, C., & Shubrook, J. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1771047 · Cited by 193
Chen, S., Fan, S., Qiao, Z., Wu, Z., Lin, B., Li, Z., Riegler, M. A., Wong, M. Y. H., Opheim, A., Korostynska, O., et al. (2025) · Advanced Materials · doi:10.1002/adma.202500412 · Cited by 164
Jones, A. G., McDonald, T. J., Shields, B. M., Hill, A. V., Hyde, C. J., Knight, B. A., & Hattersley, A. T. (2016) · Diabetes Care · doi:10.2337/dc15-0258 · Cited by 178
Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases?
Diaz-Vegas, A., Sanchez-Aguilera, P., Krycer, J. R., Morales, P. E., Monsalves-Alvarez, M., Cifuentes, M., Rothermel, B. A., & Lavandero, S. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa005 · Cited by 175
Walaszczyk, E., Luijten, M., Spijkerman, A. M. W., Bonder, M. J., Lutgers, H. L., Snieder, H., Wolffenbuttel, B. H. R., & van Vliet-Ostaptchouk, J. V. (2018) · Diabetologia · doi:10.1007/s00125-017-4497-7 · Cited by 162
Mathieu, C., Ranetti, A.-E., Li, D., Ekholm, E., Cook, W., Hirshberg, B., Chen, H., Hansen, L., & Iqbal, N. (2015) · Diabetes Care · doi:10.2337/dc15-0779 · Cited by 154
Ding, L., Li, J., Song, B., Xu, X., Zhang, B., Qi, M., Huang, W., Yang, L., & Wang, Z. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.05.011 · Cited by 174
Glucagon‐like peptide‐1‐based therapies and cardiovascular disease: looking beyond glycaemic control
Anagnostis, P. G., Athyros, V. G., Adamidou, F., Panagiotou, A., Kita, M. D., Karagiannis, A. I., & Mikhailidis, D. P. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01345.x · Cited by 149
Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives
Borse, S., Chhipa, A. S., Sharma, V., Singh, D. P., & Nivsarkar, M. (2020) · Medical Principles and Practice · doi:10.1159/000511002 · Cited by 172
Hypoglycemic agents and potential anti-inflammatory activity
Mathews, S. T., Kothari, V. M., & Galdo, J. A. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s86917 · Cited by 157
Involvement of TRPV1 Channels in Energy Homeostasis
Christie, S., Wittert, G., Li, H., & Page, A. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00420 · Cited by 144
Demmer, R. T., Jacobs, D. R., Singh, R., Zuk, A. M., ROSENBAUM, M. S., Papapanou, P. N., & Desvarieux, M. (2015) · Journal of Dental Research · doi:10.1177/0022034515590369 · Cited by 123
Effects of Polyphenols on Insulin Resistance
Williamson, G., & Sheedy, K. (2020) · Nutrients · doi:10.3390/nu12103135 · Cited by 137
Recent advances in understanding the genetic architecture of type 2 diabetes
Mohlke, K. L., & Boehnke, M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv264 · Cited by 124
Kristian, R. E. T. T., & Gottwald‐Hostalek, U. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1601455 · Cited by 136
Β cell dysfunction exists more than 5 years before type 1 diabetes diagnosis
Evans-Molina, C., Sims, E. K., DiMeglio, L. A., Ismail, H. M., Steck, A. K., Palmer, J. P., Krischer, J. P., Geyer, S., Xu, P., Sosenko, J. M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120877 · Cited by 116
“However, few studies have analyzed whether genes associated with impaired β cell function in T2D might be similarly associated with T1D.”
ResultInfluentialAMP-Activated Protein Kinase and Metabolic Control
Viollet, B., & Andréelli, F. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_13 · Cited by 121
Burns, S. M., Vetere, A., Walpita, D., Dančík, V., Khodier, C., Perez, J. R., Clemons, P. A., Wagner, B. K., & Altshuler, D. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.010 · Cited by 108
SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes
Wu, X., Liu, H., Brooks, A. C., Xu, S., Luo, J., Steiner, R., Mickelsen, D. M., Moravec, C. S., Alexis, J. D., Small, E. M., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.318988 · Cited by 102
Zhu, D., Gan, S., Liu, Y., Ma, J., Dong, X., Song, W., Zeng, J., Wang, G., Zhao, W., Zhang, Q., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30105-0 · Cited by 96
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling
Whittington, H. J., Harding, I., Stephenson, C., Bell, R., Hausenloy, D. J., Mocanu, M. M., & Yellon, D. M. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt140 · Cited by 91
Ajjan, R. A., Jackson, N., & Thomson, S. A. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827456 · Cited by 79
Zambrowicz, B., Ding, Z., Ogbaa, I., Frazier, K., Banks, P. L., Turnage, A., Freiman, J. P., Smith, M. G., Ruff, D. A., Sands, A., et al. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.01.010 · Cited by 84
Benson, G. A., Sidebottom, A. C., Hayes, J., Miedema, M. D., Boucher, J. L., Vacquier, M. C., Sillah, A., Gamam, S., & VanWormer, J. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.11.013 · Cited by 81
Aldrich, B. T., Schlötzer-Schrehardt, U. M., Skeie, J. M., Burckart, K. A., Schmidt, G. A., Reed, C. R., Zimmerman, M. B., Kruse, F. E., & Greiner, M. A. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-21094 · Cited by 77
Patients’ Use of Social Media for Diabetes Self-Care: Systematic Review
Elnaggar, A., Park, V. T., Lee, S. J., Bender, M. S., Siegmund, L. A., & Park, L. G. (2020) · Journal of Medical Internet Research · doi:10.2196/14209 · Cited by 86
Kousaxidis, A., Petrou, A., Lavrentaki, V., Fesatidou, M., Nicolaou, I., & Geronikaki, A. A. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112742 · Cited by 77
Yang, W., Zhu, D., Gan, S., Dong, X., Su, J.-P., Li, W., Jiang, H., Zhao, W., Yao, M., Song, W., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01803-5 · Cited by 79
Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study
Brahimaj, A., Ligthart, S., Ghanbari, M., Ikram, M. A., Albert Hofman, D., Franco, O. H., Kavousi, M., & Dehghan, A. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0236-0 · Cited by 83
Does vitamin D play a significant role in type 2 diabetes?
Sheth, J. J., Shah, A., Sheth, F. J., Trivedi, S. N., Lele, M., Shah, N., Thakor, P., & Vaidya, R. A. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0003-8 · Cited by 72
Macedo, A. F., Douglas, I., Smeeth, L. L., Forbes, H. J., & Ebrahim, S. B. J. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-85 · Cited by 77
Macha, S., Rose, P. W., Mattheus, M., Cinca, R., Pinnetti, S., Broedl, U. C., & Woerle, H. J. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12183 · Cited by 72
HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes
Waldman, B., Jenkins, A. J., Davis, T. M. E., Taskinen, M., Scott, R. S., O'Connell, R. L., Gebski, V., Ng, M., & KEECH, A. C. (2014) · Diabetes Care · doi:10.2337/dc13-2738 · Cited by 70
Marrif, H. I., & Alsunousi, S. I. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00083 · Cited by 85
Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options
Cornell, S. A. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s67387 · Cited by 71
Verkest, K. R., Rand, J. S., Fleeman, L. M., & Morton, J. M. (2011) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2011.10.002 · Cited by 73
Sylvester, A. L., Zhang, D. X., Ran, S., & Zinkevich, N. S. (2022) · Biomolecules · doi:10.3390/biom12060823 · Cited by 68
Vitamin D deficiency in the aetiology of obesity‐related insulin resistance
Pramono, A., Jocken, J. W. E., & Blaak, E. E. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3146 · Cited by 73
The Gut Microbial Endocrine Organ in Type 2 Diabetes
Massey, W. J., & Brown, J. M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa235 · Cited by 66
Uncovering the universality of self-replication in protein aggregation and its link to disease
Meisl, G., Xu, C. K., Taylor, J. D., Michaels, T. C. T., Levin, A., Otzen, D. E., Klenerman, D., Matthews, S., Linse, S. S., Andreasen, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn6831 · Cited by 60
Seufert, J. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s90662 · Cited by 61
Adherence to type 2 diabetes management
Khunti, N., Khunti, N., & Khunti, K. (2019) · British Journal of Diabetes · doi:10.15277/bjd.2019.223 · Cited by 77
Guess, N. D. (2018) · Nutrients · doi:10.3390/nu10091245 · Cited by 75
Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue
Georgiadi, A., Lopez‐Salazar, V., El‐Merahbi, R., Karikari, R. A., Ma, X., Mourão, A., Klepac, K., Bühler, L., Alfaro, A. J., Kaczmarek, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22579-1 · Cited by 61
The association of dyslipidemia and obesity with glycated hemoglobin
Sheth, J. J., Shah, A., Sheth, F. J., Trivedi, S. N., Nabar, N., Shah, N., Thakor, P., & Vaidya, R. A. (2015) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-015-0004-6 · Cited by 56
Carretero, R. G., Vigil, L., Mora-Jiménez, I., Soguero-Ruíz, C., Barquero‐Pérez, Ó., & Ramos, J. (2020) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-020-02132-w · Cited by 61
McGlone, E. R., Carey, I. M., Veličković, V. M., Chana, P., Mahawar, K. K., Batterham, R. L., Hopkins, J. C. A., Walton, P., Kinsman, R., Byrne, J. P., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003228 · Cited by 57
Abramson, A., Halperin, F., Kim, J., & Traverso, G. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.04.022 · Cited by 60
Tan, D., Tseng, H. H. L., Zhong, Z., Wang, S., Vong, C. T., & Wang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231910988 · Cited by 57
Zhu, J., Jin, J., Ding, J., Li, S., Cen, P., Wang, K., Wang, H., & Xia, J. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.05.014 · Cited by 55
Pereira, S. S., Guimarães, M., Almeida, R., Pereira, A. M., Lobato, C. B., Hartmann, B., Hilsted, L., Holst, J. J., Nora, M. C., & Monteiro, M. P. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0282-z · Cited by 54
Effect of diabetes on exosomal miRNA profile in patients with obesity
Kim, H., Bae, Y., Lee, H., Kim, H., Jeon, J. S., Noh, H., Han, D. C., Byun, D. W., Kim, S. H., Park, H. K., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001403 · Cited by 56
Jude, E. B., Malecki, M. T., Gomez Huelgas, R., Prazny, M., Snoek, F., Tankova, T., Giugliano, D., & Khunti, K. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01222-2 · Cited by 52
Five-Year Efficacy and Safety Data of Exenatide Once Weekly
Wysham, C., MacConell, L., Maggs, D. G., Zhou, M., Griffin, P. S., & TRAUTMANN, M. E. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.01.008 · Cited by 57
The chemistry of gut microbiome in health and diseases
Lau, A., Tan, L. T., Mutalib, N. A., Wong, S. H., Letchumanan, V., & Lee, L. (2021) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000175 · Cited by 59
Moin, A. S. M., Dhawan, S., Cory, M., Butler, P. C., Rizza, R. A., & Butler, A. E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2496 · Cited by 53
Owens, D. R., Monnier, L., & Barnett, A. H. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12977 · Cited by 57
Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial
McInnes, N., Smith, A., Otto, R., Vandermey, J., Punthakee, Z., Sherifali, D., Balasubramanian, K., Hall, S., & Gerstein, H. C. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3373 · Cited by 59
The scientific basis for healthful carbohydrate profile
Lamothe, L. M., Lê, K., Samra, R. A., Roger, O., Green, H., & Macé, K. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1392287 · Cited by 56
Grubb, A. L., McDonald, T. J., Rutters, F., Donnelly, L. A., Hattersley, A. T., Oram, R. A., Palmer, C. N. A., van der Heijden, A. A. W. A., Carr, F., Elders, P. J. M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0431 · Cited by 54
Low carbohydrate dietary approaches for people with type 2 diabetes-a narrative review
Wheatley, S. D., Deakin, T. A., Arjomandkhah, N. C., Hollinrake, P. B., & Reeves, T. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.687658 · Cited by 50
Oyenihi, A. B., Chegou, N. N., Oguntibeju, O. O., & Masola, B. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1318293 · Cited by 50
Hou, J., Li, Z., Zhong, W., Hao, Q., Lei, L., Wang, L., Zhao, D., Xu, P., Zhou, Y., Wang, Y., et al. (2017) · Diabetes · doi:10.2337/db16-1305 · Cited by 55
Clinical profile and outcome in patients of diabetic foot infection
Seth, A., Attri, A., Kataria, H., Kochhar, S., Seth, S., & Gautam, N. (2019) · International Journal of Applied and Basic Medical Research · doi:10.4103/ijabmr.ijabmr_278_18 · Cited by 50
Milk in the prevention and management of type 2 diabetes: The potential role of milk proteins
Hidayat, K., Du, X., & Shi, B. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3187 · Cited by 54
Loprinzi, P. D., & Ramulu, P. Y. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.05.015 · Cited by 54
Metabolic Syndrome in Polycystic Ovary Syndrome
Pasquali, R. (2018) · Frontiers of hormone research · doi:10.1159/000485995 · Cited by 58
Experimental diets dictate the metabolic benefits of probiotics in obesity
Larsen, I., Choi, B. S.-Y., Föh, B., Kristensen, N. N., Ouellette, A., Haller, R. F., Olsen, P., Saulnier, D. M. A., Sina, C., Jensen, B. A. H., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2192547 · Cited by 50
Dietary Protein Is Important in the Practical Management of Prediabetes and Type 2 Diabetes
Campbell, A. P., & Rains, T. M. (2014) · Journal of Nutrition · doi:10.3945/jn.114.194878 · Cited by 49
Use and discontinuation of insulin treatment among adults aged 75 to 79 years with type 2 diabetes
Weiner, J. Z., Gopalan, A., Mishra, P., Lipska, K. J., Huang, E. S., Laiteerapong, N., Karter, A. J., & Grant, R. W. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.3759 · Cited by 47
Shrivastava, T. P., Goswami, S., Gupta, R., & Goyal, R. K. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211060060 · Cited by 46
Lyu, X., Zhu, X., Zhao, B., Du, L., Chen, D., Wang, C., Liu, G., & Ran, X. (2017) · Scientific Reports · doi:10.1038/srep44865 · Cited by 50
Kumar, D., Shankar, K., Patel, S., Gupta, A., Varshney, S., Gupta, S., Rajan, S., Srivastava, A., Vishwakarma, A. L., & Gaikwad, A. N. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.05.010 · Cited by 55
Rodbard, H. W., Tripathy, D., Vidrio-Velázquez, M., Demissie, M., Tamer, S. C., & Piletič, M. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12955 · Cited by 46
Dapagliflozin: A new sodium–glucose cotransporter 2 inhibitor for treatment of type 2 diabetes
Vivian, E. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140168 · Cited by 45
A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models
Wirth, F., Heitz, F. D., Seeger, C., Combaluzier, I., Breu, K., Denroche, H. C., Thévenet, J., Osto, M., Arosio, P., Kerr-Conte, J. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41986-0 · Cited by 46
Pallayová, M., Steele, K. E., Magnuson, T. H., Schweitzer, M., Hill, N. R., Bevans‐Fonti, S., & Schwartz, A. R. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-83 · Cited by 46
Assessing the Impact of Diabetes Mellitus on Donor Corneal Endothelial Cell Density
Liaboe, C. A., Aldrich, B. T., Carter, P. C., Skeie, J. M., Burckart, K. A., Schmidt, G. A., Reed, C. R., Zimmerman, M. B., & Greiner, M. A. (2017) · Cornea · doi:10.1097/ico.0000000000001174 · Cited by 44
Bermúdez‐Millán, A., Wagner, J. A., Feinn, R., Segura‐Pérez, S., Damio, G., Chhabra, J., & Pérez‐Escamilla, R. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz021 · Cited by 51
van Baar, A. C. G., Deviere, J. M. E., Hopkins, D., Crenier, L., Holleman, F., Neto, M. G., Becerra, P., Vignolo, P., Grunert, L. R., Mingrone, G., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109194 · Cited by 45
The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis
Graus-Nunes, F., & Souza-Mello, V. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.191 · Cited by 43
Effect of low carbohydrate diets on insulin resistance and the metabolic syndrome
Foley, P. J. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000659 · Cited by 47
Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes
Chaiyakunapruk, N., Tan, X., Liang, Y. M., Guevarra, M., Xie, L., & CHENG, A. Y. Y. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02737-1 · Cited by 46
Association of vitamin D deficiency with insulin resistance in middle-aged type 2 diabetics
Dhas, Y., Banerjee, J., Damle, G., & Mishra, N. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.02.014 · Cited by 48
Raskin, P. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2403 · Cited by 42
González-Franquesa, A., Gama-Pérez, P., Kulis, M., Szczepanowska, K., Dahdah, N., Moreno-Gomez, S., Latorre, A., Fernandez‐Ruiz, R., Aguilar‐Mogas, A., Hoffman, A., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102353 · Cited by 48
Metadata
- Authors
- Fonseca, V. A.
- Affiliations
- Tulane University (US)
- Corresponding author
- Fonseca, Vivian A.
- ORCID
- Fonseca, Vivian A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S151-S156
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811457
- OpenAlex
- W2128050336
- Cited by
- 573
- References
- 40
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 50 · 2023: 51 · 2022: 41 · 2021: 51 · 2020: 54 · 2019: 50 · 2018: 43 · 2017: 37 · 2016: 43 · 2015: 37 · 2014: 23 · 2013: 17 · 2012: 7
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes progression, beta-cell function decline, insulin resistance, hyperglycemia, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, microvascular complications, cardiovascular risk
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin Resistance, Obesity, Prediabetic State, Weight Gain, Disease Progression, Postprandial Period, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.